Order Article Reprints

Coudriet GM, Delmastro-Greenwood MM, Previte DM, Marré ML, O’Connor EC, Novak EA, Vincent G, Mollen KP, Lee S, Dong HH, et al. Treatment with a Catalytic Superoxide Dismutase (SOD) Mimetic Improves Liver Steatosis, Insulin Sensitivity, and Inflammation in Obesity-Induced Type 2 Diabetes. Antioxidants. 2017; 6(4):85. https://doi.org/10.3390/antiox6040085

Coudriet, Gina M., Meghan M. Delmastro-Greenwood, Dana M. Previte, Meghan L. Marré, Erin C. O’Connor, Elizabeth A. Novak, Garret Vincent, Kevin P. Mollen, Sojin Lee, H. Henry Dong, and et al. 2017. "Treatment with a Catalytic Superoxide Dismutase (SOD) Mimetic Improves Liver Steatosis, Insulin Sensitivity, and Inflammation in Obesity-Induced Type 2 Diabetes" Antioxidants 6, no. 4: 85. https://doi.org/10.3390/antiox6040085

Coudriet, G. M., Delmastro-Greenwood, M. M., Previte, D. M., Marré, M. L., O’Connor, E. C., Novak, E. A., Vincent, G., Mollen, K. P., Lee, S., Dong, H. H., & Piganelli, J. D. (2017). Treatment with a Catalytic Superoxide Dismutase (SOD) Mimetic Improves Liver Steatosis, Insulin Sensitivity, and Inflammation in Obesity-Induced Type 2 Diabetes. Antioxidants, 6(4), 85. https://doi.org/10.3390/antiox6040085